Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Merriman

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Oncology Reports|May 24, 2008
CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivoI Hubeek, E M Comijn, C L Van der Wilt, et al.
Anticancer Research|July 1, 1995
In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmanninR M Schultz, R L Merriman, S L Andis, et al.
Biochemical and Biophysical Research Communications|April 15, 1991
Inhibition of protein kinase C by calphostin C is light-dependentR F Bruns, F D Miller, R L Merriman, et al.
The Prostate|January 1, 1986
Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the ratB L Neubauer, K G Bemis, K L Best, et al.
The Journal of Urology|January 1, 1986
Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the ratB L Neubauer, K G Bemis, K L Best, et al.
Investigational New Drugs|January 1, 1996
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft modelsR L Merriman, L W Hertel, R M Schultz, et al.
Thrombosis Research|April 1, 1988
Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the ratG F Smith, B L Neubauer, J L Sundboom, et al.
Cancer Research|September 1, 1992
Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinomaB L Neubauer, K L Best, R L Goode, et al.
Oncology Research|January 1, 1993
Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenograftsR M Schultz, R L Merriman, J E Toth, et al.
The Prostate|October 1, 1995
Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma modelB L Neubauer, K L Best, D F Counts, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Oncology Reports|May 24, 2008
CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivoI Hubeek, E M Comijn, C L Van der Wilt, et al.
Anticancer Research|July 1, 1995
In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmanninR M Schultz, R L Merriman, S L Andis, et al.
Biochemical and Biophysical Research Communications|April 15, 1991
Inhibition of protein kinase C by calphostin C is light-dependentR F Bruns, F D Miller, R L Merriman, et al.
The Prostate|January 1, 1986
Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the ratB L Neubauer, K G Bemis, K L Best, et al.
The Journal of Urology|January 1, 1986
Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the ratB L Neubauer, K G Bemis, K L Best, et al.
Investigational New Drugs|January 1, 1996
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft modelsR L Merriman, L W Hertel, R M Schultz, et al.
Thrombosis Research|April 1, 1988
Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the ratG F Smith, B L Neubauer, J L Sundboom, et al.
Cancer Research|September 1, 1992
Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinomaB L Neubauer, K L Best, R L Goode, et al.
Oncology Research|January 1, 1993
Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenograftsR M Schultz, R L Merriman, J E Toth, et al.
The Prostate|October 1, 1995
Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma modelB L Neubauer, K L Best, D F Counts, et al.
Pageof 5